Global Animal Pharmaceuticals Market Size, Share, Trends, Industry Growth by Product Type (Antibiotics, Vaccines, Anti-parasitics, Anti-inflammatory Drugs, Others), by Animal Type (Companion Animals, Livestock Animals), by Route of Administration, by Distribution Channel, and Region, and Forecast to 2030

Report ID: RCMA824 | Report Format: PDF + Excel | Starting Price: 3600/- USD |

The global animal pharmaceuticals market is anticipated to grow at a significant CAGR of around 7% during the forecast period from 2024 to 2030. The market is propelled by a convergence of dynamic factors that collectively shape its growth and trajectory. The surge in pet ownership globally, driven by urbanization and evolving lifestyles, underpins a heightened demand for pharmaceuticals tailored to companion animals. Concurrently, the imperative to meet escalating demands for livestock products fuels the reliance on effective pharmaceutical solutions in the agricultural sector. The prevalence of infectious diseases necessitates ongoing pharmaceutical innovation, while advancements in veterinary medicine contribute to groundbreaking developments. Regulatory support, investments in research and development, and a heightened awareness of animal health further bolster the market. The globalization of animal health services, technological integration, and the “One Health” approach emphasizing interconnected human, animal, and environmental health collectively contribute to the multifaceted and dynamic landscape of the global market.

Market Snapshot:

Benchmark Year 2022
Market Size lock
Market Growth (CAGR) ~ 7% (2023-2030)
Largest Market Share North America
Analysis Period 2020-2030
Market Players Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, and Ceva Santé Animale

To know more about the research study, request sample papers

Market Drivers:

  • Increasing Pet Ownership: The surge in urbanization, changing societal norms, and evolving lifestyles have led to a notable increase in pet ownership globally. As more individuals and families welcome pets into their homes, there is a subsequent rise in demand for veterinary services and pharmaceuticals tailored to companion animals. This trend underscores the importance of addressing various health conditions and ensuring the overall well-being of pets, driving growth in the animal pharmaceuticals sector.
  • Growing Demand for Livestock Products: With the global population on the rise, the demand for essential commodities such as meat, milk, and eggs continues to escalate. Livestock producers face the challenge of maintaining animal health and productivity to meet consumer demands. Consequently, there is a heightened reliance on effective pharmaceutical solutions to manage diseases, enhance growth rates, and optimize production efficiency in livestock, thereby stimulating growth in the animal pharmaceuticals market.
  • Prevalence of Animal Diseases: The veterinary and animal health landscape is marked by the presence of various infectious, parasitic, and non-infectious diseases affecting animals. These diseases pose significant economic and health challenges for animal populations, necessitating the development and deployment of pharmaceutical interventions. Addressing prevalent diseases through targeted pharmaceutical solutions remains paramount, driving the demand for innovative and effective animal health products.
  • Advancements in Veterinary Medicine: The continuous evolution of veterinary science and medicine contributes to groundbreaking advancements in animal health management. This progress translates into the development of novel pharmaceutical products, including vaccines, antibiotics, therapeutic agents, and specialized treatments, addressing a myriad of health conditions in diverse animal species. The pursuit of excellence and innovation in veterinary medicine fosters growth opportunities and shapes the future trajectory of the animal pharmaceuticals market.
  • Regulatory Support and Compliance: A conducive regulatory environment and stringent quality standards are essential pillars supporting the animal pharmaceuticals market’s growth and sustainability. Regulatory frameworks governing the approval, manufacturing, distribution, and use of animal pharmaceuticals ensure product safety, efficacy, and compliance with established guidelines. Adherence to regulatory requirements and continuous monitoring and evaluation processes contribute to building consumer confidence and maintaining market integrity.
  • Increasing Investments in Research and Development: The pursuit of innovation and excellence drives significant investments in research and development within the animal pharmaceuticals industry. Leading pharmaceutical companies, research institutions, and academic organizations collaborate to explore emerging trends, identify unmet needs, and develop next-generation animal health solutions. This commitment to research and innovation fuels the development of advanced pharmaceutical products, paving the way for enhanced animal health outcomes and market growth.
  • Rising Awareness of Animal Health: Growing awareness among pet owners, livestock producers, and animal caretakers about the significance of preventive healthcare, disease management, and responsible animal husbandry practices fosters a conducive environment for the animal pharmaceuticals market. Education, awareness campaigns, and outreach programs emphasize the importance of vaccination, regular check-ups, and timely treatment interventions, fostering a culture of proactive animal health management.
  • Globalization of Animal Health Services: The interconnectedness of global markets, trade networks, and supply chains in the animal health sector underscores the importance of standardized, effective, and reliable pharmaceutical solutions. As veterinary services, products, and expertise transcend geographical boundaries, there is an increasing demand for pharmaceuticals that meet international quality standards, regulatory requirements, and market expectations, driving growth in the global animal pharmaceuticals market.

Market Insights:

The global animal pharmaceuticals market is bifurcated into product type, animal type, route of administration, distribution channel, and geography. On the basis of product type, the market is further segmented into antibiotics, vaccines, anti-parasitics, anti-inflammatory drugs, and others. Vaccines segment have consistently held a crucial position, emerging as a prominent segment due to their integral role in preventive healthcare for both companion animals and livestock. The emphasis on disease prevention and control, particularly in the face of infectious diseases, has propelled the demand for vaccines. On the other side, the anti-parasitics addressing the prevalent issue of parasitic infestations in animals. Livestock, in particular, is susceptible to various parasites that can impact their health and productivity, making effective anti-parasitic medications essential. Factors influencing dominance include disease prevalence, the preventive focus of specific segments, evolving market trends, and the regulatory environment.

  • Antibiotics: Antibiotics for animals are medications designed to combat bacterial infections. They play a crucial role in veterinary medicine by addressing a range of bacterial illnesses, promoting animal health and preventing the spread of infectious diseases.
  • Vaccines: Veterinary vaccines are essential for preventing and controlling diseases in animals. These products stimulate an immune response in animals, providing immunity against specific diseases. Vaccination is a fundamental component of preventive healthcare in both companion animals and livestock.
  • Anti-parasitics: Anti-parasitic medications are designed to control and eliminate parasitic infestations in animals. These parasites may include worms, ticks, fleas, and other external or internal parasites. Anti-parasitics are crucial for maintaining animal health and preventing parasitic-related diseases.
  • Anti-inflammatory Drugs: Anti-inflammatory drugs for animals are medications that reduce inflammation and alleviate pain. They are used to manage conditions such as arthritis, injuries, and other inflammatory disorders in both companion animals and livestock.
  • Others: This category encompasses a diverse range of animal pharmaceuticals that may include analgesics, hormones, steroids, and various therapeutic agents designed for specific health conditions. The “Others” category reflects the broad spectrum of pharmaceutical products beyond the primary classifications.

The animal pharmaceuticals market research report presents the analysis of each segment from 2020 to 2030 considering 2022 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2023 to 2030.

Historical & Forecast Period

  • 2020-21 – Historical Year
  • 2022 – Base Year
  • 2023-2030 – Forecast Period

Market Segmentation:

By Product Type:

  • Antibiotics
  • Vaccines
  • Anti-parasitics
  • Anti-inflammatory Drugs
  • Others

By Animal Type:

  • Companion Animals
  • Livestock Animals

By Route of Administration:

  • Oral Medications
  • Injectable Medications
  • Topical Medications

By Distribution Channel:

  • Veterinary Hospitals & Clinics
  • Pharmacies & Retail Stores
  • E-Commerce stores

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regional Analysis:

Geographically, North America dominated the global animal pharmaceuticals market in the benchmark year due to the combination of advanced veterinary infrastructure, high rates of pet ownership, and extensive livestock production. The region boasts a well-established healthcare system for animals, including state-of-the-art veterinary clinics and research facilities, contributing to the development and distribution of cutting-edge pharmaceuticals. With a significant portion of households owning pets, there is a substantial demand for companion animal pharmaceuticals, reflecting a cultural emphasis on pet care.

Simultaneously, the expansive livestock industry in North America, encompassing cattle, poultry, and swine, relies heavily on pharmaceuticals to maintain the health and productivity of these animals. The stringent regulatory standards in the region ensure product safety and efficacy, while the economic strength of North American countries enables substantial investments in veterinary care and pharmaceutical products.

Moreover, North America’s leadership is also propelled by its early adoption of technological advancements in veterinary medicine. Innovations in diagnostics, treatment modalities, and pharmaceutical development contribute to the region’s reputation for staying at the forefront of veterinary healthcare. While market dynamics can evolve, North America’s dominance in the animal pharmaceuticals sector persists due to a confluence of factors, making it a pivotal player in shaping the trajectory of the global market.

Competitive Assessment:

Some of the prominent market players operating in the global animal pharmaceuticals market are Zoetis Inc., Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, and Ceva Santé Animale. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Recent Developments:

  • In November 2023, Virbac solidified its position as a key player in the Indian poultry vaccines market by acquiring a majority stake in Globion, a prominent poultry vaccines company based in India. This strategic move not only bolstered Virbac’s standing but also expanded Virbac India’s poultry portfolio, further establishing the company as a leading entity in the animal health sector within India.
  • In October 2023, Merck Animal Health introduced gilvetmab, its caninized monoclonal antibody, to board-certified veterinary oncologists in the United States. The product, which has received conditional licensing from the USDA’s Center for Veterinary Biologics (CVB), is designed to address canine melanoma and mast cell cancers. This advancement showcases Merck Animal Health’s commitment to providing innovative solutions in the field of veterinary oncology, offering a promising option for the treatment of these specific canine cancers.
  • In May 2023, Merck Animal Health achieved regulatory approval for BRAVECTO QUANTUM (fluralaner) in Australia. This notable development positions BRAVECTO QUANTUM as the sole injectable parasiticide capable of providing dogs with up to a full year of protection against fleas and ticks. The approval underscores Merck Animal Health’s dedication to advancing parasiticide solutions and enhancing the overall well-being of dogs, marking a significant milestone in the Australian market.

Key Companies:

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Bayer Animal Health
  • Ceva Santé Animale
  • Virbac
  • Vetoquinol
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • Norbrook Laboratories
  • IDEXX Laboratories

Key Questions Answered by Animal Pharmaceuticals Market Report

  • Global animal pharmaceuticals market forecasts from 2023-2030
  • Regional market forecasts from 2023-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2023-2030 covering 15 major countries from the regions as mentioned above
  • Animal pharmaceuticals submarket forecasts from 2023-2030 covering the market by product type, animal type, route of administration, distribution channel, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis about the market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level animal pharmaceuticals markets from 2023-2030
  • Competitive Landscape and market positioning of top 10 players operating in the market
Animal Pharmaceuticals Market
Table of Contents:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Animal Pharmaceuticals Market Portraiture
2.2. Global Animal Pharmaceuticals Market, by Product Type, 2022 (USD Mn)
2.3. Global Animal Pharmaceuticals Market, by Animal Type, 2022 (USD Mn)
2.4. Global Animal Pharmaceuticals Market, by Route of Administration, 2022 (USD Mn)
2.5. Global Animal Pharmaceuticals Market, by Distribution Channel, 2022 (USD Mn)
2.6. Global Animal Pharmaceuticals Market, by Geography, 2022 (USD Mn)

 

3. Global Animal Pharmaceuticals Market Analysis


3.1. Animal Pharmaceuticals Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. Porter’s Five Force Analysis
3.6.1. Bargaining Power of Suppliers
3.6.2. Bargaining Power of Buyers
3.6.3. Threat of New Entrants
3.6.4. Threat of Substitutes
3.6.5. Degree of Competition
3.7. PESTLE Analysis

 

4. Global Animal Pharmaceuticals Market by Product Type, 2020 – 2030 (USD Mn)


4.1. Overview
4.2. Antibiotics
4.3. Vaccines
4.4. Anti-parasitics
4.5. Anti-inflammatory Drugs
4.6. Others

 

5. Global Animal Pharmaceuticals Market by Animal Type, 2020 – 2030 (USD Mn)


5.1. Overview
5.2. Companion Animals
5.3. Livestock Animals

 

6. Global Animal Pharmaceuticals Market by Route of Administration, 2020 – 2030 (USD Mn)


6.1. Overview
6.2. Oral Medications
6.3. Injectable Medications
6.4. Topical Medications

 

7. Global Animal Pharmaceuticals Market by Distribution Channel, 2020 – 2030 (USD Mn)


7.1. Overview
7.2. Veterinary Hospitals & Clinics
7.3. Pharmacies & Retail Stores
7.4. E-Commerce stores

 

8. North America Animal Pharmaceuticals Market Analysis and Forecast, 2020 – 2030 (USD Mn)


8.1. Overview
8.2. North America Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
8.3. North America Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
8.4. North America Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
8.5. North America Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
8.6. North America Animal Pharmaceuticals Market by Country, (2020-2030 USD Mn)
8.6.1. U.S.
8.6.1.1. U.S. Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
8.6.1.2. U.S. Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
8.6.1.3. U.S. Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
8.6.1.4. U.S. Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
8.6.2. Canada
8.6.2.1. Canada Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
8.6.2.2. Canada Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
8.6.2.3. Canada Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
8.6.2.4. Canada Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
8.6.3. Mexico
8.6.3.1. Mexico Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
8.6.3.2. Mexico Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
8.6.3.3. Mexico Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
8.6.3.4. Mexico Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)

 

9. Europe Animal Pharmaceuticals Market Analysis and Forecast, 2020 - 2030 (USD Mn)


9.1. Overview
9.2. Europe Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.3. Europe Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.4. Europe Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.5. Europe Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6. Europe Animal Pharmaceuticals Market by Country, (2020-2030 USD Mn)
9.6.1. Germany
9.6.1.1. Germany Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.1.2. Germany Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.1.3. Germany Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.1.4. Germany Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6.2. U.K.
9.6.2.1. U.K. Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.2.2. U.K. Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.2.3. U.K. Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.2.4. U.K. Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6.3. France
9.6.3.1. France Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.3.2. France Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.3.3. France Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.3.4. France Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6.4. Spain
9.6.4.1. Spain Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.4.2. Spain Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.4.3. Spain Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.4.4. Spain Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6.5. Italy
9.6.5.1. Italy Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.5.2. Italy Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.5.3. Italy Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.5.4. Italy Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
9.6.6. Rest of Europe
9.6.6.1. Rest of Europe Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
9.6.6.2. Rest of Europe Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
9.6.6.3. Rest of Europe Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
9.6.6.4. Rest of Europe Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)

 

10. Asia Pacific Animal Pharmaceuticals Market Analysis and Forecast, 2020 - 2030 (USD Mn)


10.1. Overview
10.2. Asia Pacific Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.3. Asia Pacific Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.4. Asia Pacific Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.5. Asia Pacific Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
10.6. Asia Pacific Animal Pharmaceuticals Market by Country, (2020-2030 USD Mn)
10.6.1. China
10.6.1.1. China Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.6.1.2. China Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.6.1.3. China Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.6.1.4. China Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
10.6.2. Japan
10.6.2.1. Japan Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.6.2.2. Japan Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.6.2.3. Japan Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.6.2.4. Japan Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
10.6.3. India
10.6.3.1. India Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.6.3.2. India Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.6.3.3. India Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.6.3.4. India Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
10.6.4. South Korea
10.6.4.1. South Korea Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.6.4.2. South Korea Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.6.4.3. South Korea Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.6.4.4. South Korea Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
10.6.5. Rest of Asia Pacific
10.6.5.1. Rest of Asia Pacific Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
10.6.5.2. Rest of Asia Pacific Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
10.6.5.3. Rest of Asia Pacific Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
10.6.5.4. Rest of Asia Pacific Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)

 

11. Latin America (LATAM) Animal Pharmaceuticals Market Analysis and Forecast, 2020 - 2030 (USD Mn)


11.1. Overview
11.2. Latin America Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
11.3. Latin America Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
11.4. Latin America Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
11.5. Latin America Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
11.6. Latin America Animal Pharmaceuticals Market by Country, (2020-2030 USD Mn)
11.6.1. Brazil
11.6.1.1. Brazil Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
11.6.1.2. Brazil Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
11.6.1.3. Brazil Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
11.6.1.4. Brazil Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
11.6.2. Argentina
11.6.2.1. Argentina Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
11.6.2.2. Argentina Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
11.6.2.3. Argentina Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
11.6.2.4. Argentina Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
11.6.3. Rest of Latin America
11.6.3.1. Rest of Latin America Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
11.6.3.2. Rest of Latin America Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
11.6.3.3. Rest of Latin America Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
11.6.3.4. Rest of Latin America Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)

 

12. Middle East and Africa Animal Pharmaceuticals Market Analysis and Forecast, 2020 - 2030 (USD Mn)


12.1. Overview
12.2. MEA Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
12.3. MEA Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
12.4. MEA Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
12.5. MEA Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
12.6. Middle East and Africa Animal Pharmaceuticals Market, by Country, (2020-2030 USD Mn)
12.6.1. GCC
12.6.1.1. GCC Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
12.6.1.2. GCC Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
12.6.1.3. GCC Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
12.6.1.4. GCC Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
12.6.2. South Africa
12.6.2.1. South Africa Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
12.6.2.2. South Africa Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
12.6.2.3. South Africa Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
12.6.2.4. South Africa Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)
12.6.3. Rest of MEA
12.6.3.1. Rest of MEA Animal Pharmaceuticals Market by Product Type, (2020-2030 USD Mn)
12.6.3.2. Rest of MEA Animal Pharmaceuticals Market by Animal Type, (2020-2030 USD Mn)
12.6.3.3. Rest of MEA Animal Pharmaceuticals Market by Route of Administration, (2020-2030 USD Mn)
12.6.3.4. Rest of MEA Animal Pharmaceuticals Market by Distribution Channel, (2020-2030 USD Mn)

 

13. Competitive Landscape


13.1. Company Market Share Analysis, 2022
13.2. Competitive Dashboard
13.3. Competitive Benchmarking
13.4. Geographic Presence Heatmap Analysis
13.5. Company Evolution Matrix
13.5.1. Star
13.5.2. Pervasive
13.5.3. Emerging Leader
13.5.4. Participant
13.6. Strategic Analysis Heatmap Analysis
13.7. Key Developments and Growth Strategies
13.7.1. Mergers and Acquisitions
13.7.2. New Product Launch
13.7.3. Joint Ventures
13.7.4. Others

 

14. Company Profiles


14.1. Zoetis Inc.
14.1.1. Business Description
14.1.2. Financial Health and Budget Allocation
14.1.3. Product Positions/Portfolio
14.1.4. Recent Development
14.1.5. SWOT Analysis
14.2. Merck Animal Health
14.3. Boehringer Ingelheim Animal Health
14.4. Elanco Animal Health
14.5. Bayer Animal Health
14.6. Ceva Santé Animale
14.7. Virbac
14.8. Vetoquinol
14.9. Dechra Pharmaceuticals PLC
14.10. Phibro Animal Health Corporation
14.11. Norbrook Laboratories
14.12. IDEXX Laboratories
Fill the given form to inquiry before buying for Global Animal Pharmaceuticals Market Size, Share, Trends, Industry Growth by Product Type (Antibiotics, Vaccines, Anti-parasitics, Anti-inflammatory Drugs, Others), by Animal Type (Companion Animals, Livestock Animals), by Route of Administration, by Distribution Channel, and Region, and Forecast to 2030 Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 3600/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Global Animal Pharmaceuticals Market Size, Share, Trends, Industry Growth by Product Type (Antibiotics, Vaccines, Anti-parasitics, Anti-inflammatory Drugs, Others), by Animal Type (Companion Animals, Livestock Animals), by Route of Administration, by Distribution Channel, and Region, and Forecast to 2030 Market


Our Clients